BCL2L1 and urinary bladder cancer: Our mechanistic inquiry identified BCL-xL downregulation as a critical mediator downstream of STAT3 inhibition for sertindole-induced bladder cancer cell apoptosis, as BCL-xL overexpression protected cells from sertindole’s proapoptotic action (Figure 4).